Uptake of pneumococcal vaccination in older people in northern Israel

The 23-valent pneumococcal vaccine is recommended for people aged 65 years and over, to prevent pneumonia, a leading cause of infectious morbidity in older people. This study assessed pneumococcal vaccination in people aged 65–74 years living in northern Israel who were eligible for the pneumococcal...

全面介紹

書目詳細資料
Main Authors: Sophia Eilat-Tsanani, Ayelet Vashitz-Giwnewer
格式: Article
語言:English
出版: Elsevier 2021-12-01
叢編:Preventive Medicine Reports
主題:
在線閱讀:http://www.sciencedirect.com/science/article/pii/S2211335521002436